A Randomized parallel group clinical trial on effectiveness of Ayurvedic medicines in reducing adverse effects of radiotherapy, improving disease free survival, quality of life of oral cancer patients
Phase 2
- Conditions
- Health Condition 1: null- Health condition â??Oral cancer patients undergoing radiotherapy, Problem studied - Adverse effects of radiotherapyHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
- Registration Number
- CTRI/2017/01/007689
- Lead Sponsor
- Dr Shweta Gujar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Oral cavity cancer patients of all stages and grades, who are scheduled for radiotherapy (dose up to 6600 cGY in 30-35 fractions in 5-6 weeks), who are also treated with or without concurrent chemotherapy (Inj. Cisplatin, as booster therapy to radiotherapy)
Exclusion Criteria
Oral cavity cancer patients who have already received palliative radiotherapy and patients receiving curative chemotherapy along with radiotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method